Patent · US Active

Readthrough inducing agent and drug for treating genetic disease caused by nonsense mutation

US9358246B2 · kind B2 · utility

0Cited by

1References

6Claims

0Family size

Assignees

MICROBIAL CHEMISTRY RESEARCH FOUNDATION · JP
THE UNIVERSITY OF TOKYO · JP

Inventors

Ryoichi Matsuda · Tokyo, JP
Masataka Shiozuka · Tokyo, JP
Akira Wagatsuma · Tokyo, JP
Yoshikazu Takahashi · Nagoya, JP
Daishiro Ikeda · Oshima, JP
Yoshiaki Nonomura · Tokyo, JP
Masafumi Matsuo · Kasai, JP
Atsushi Nishida · Kasai, JP

Key dates

Filing date	Sep 15, 2014
Grant date	Jun 7, 2016
Priority date	—
Expiry date	Sep 15, 2034

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61K48/00
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

A readthrough inducing agent for inducing readthrough of a premature stop codon generated by nonsense mutations, the readthrough inducing agent comprising a compound having a structure expressed by the following Structural Formula (A), and a drug for treating a genetic disease caused by nonsense mutations, the drug comprising the readthrough inducing agent.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.